MBX Biosciences (MBX) on Monday named executive chairman Steve Hoerter as chairman and chief executive officer, succeeding co-founder Kent Hawryluk, who will step down as president, chief executive officer and a member of board.
The company said it also appointed John Smither, currently interim CFO, as chief financial officer. The executive changes are effective immediately.